Signaling pathways
-
BA2867 PrinomastatSummary: Prinomastat (AG3340) is a broad-spectrum, potent, orally active metalloproteinase inhibitor. - BA2868 TZ9Summary: TZ9 is a selective inhibitor.
- BA2869 VII-31Summary: VII-31 is a NEDDylation pathway activator that inhibits tumors in vitro and in vivo.
- BA2870 BLM-IN-1Summary: BLM-IN-1 is a potent inhibitor of Bloom syndrome proteins.
- BA2871 Thalidomide-5-OHSummary: Thalidomide-5-OH is a Thalidomide-based, protein-recruitable ligand.
- BA2872 PTC-028Summary: PTC-028 is an orally effective inhibitor of stem cell factor for the study of ovarian cancer.
- BA2873 LuxeptinibSummary: Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent inhibitor.
- BA2874 NHWD-870Summary: NHWD-870 is a potent, orally active and selective inhibitor.
- BA2875 BETd-260Summary: BETd-260 (ZBC260), a PROTAC linked by ligand and ligand-conjugated, was able to reduce protein activity at a low concentration of 30 pM in leukemia cells RS4;11.
- BA2877 SKI-178Summary: SKI-178 is a potent sphingosine kinase-1 and inhibitor.